Our Story: The Vision Behind Hypernova Bio
Founder's Note
I didn't start Hypernova Bio to build a company. I started it to solve a problem I had witnessed cause real suffering: people losing their lives not because a treatment didn't exist, but because they couldn't afford the one that did. By combining modern AI with rigorous science and by keeping research tied to real human needs, I believe we can change that story for patients everywhere.
-Het Jayant Shah, Founder and CEO
How did Hypernova Bio came into existence
The idea for Hypernova Bio took root in 2015, born from a deeply personal experience. While working in the pharmacy sector in India, I saw firsthand how unaffordable drug prices could devastate families. I watched talented, compassionate caregivers fight to help patients with almost no resources. And too often, lives were lost, not because medicine didn't exist, but because it sat out of financial reach.
That reality changed the course of my career. I came to the United States to pursue my master's degree at Fairleigh Dickinson University, where I deepened my scientific expertise and broadened my perspective, driven by a single question:
"How can I use my scientific knowledge, industry experience, and passion to deliver better medicines to the people who need them most, at prices they can actually afford?"
After completing my master's, I spent the following years in the field: leading drug development programs, working at the frontier of analytical science, and building a network of collaborators across the industry. By 2025, that experience had crystallized into a clear vision and a company built to pursue it.
A New Dimension for Drug Revival & Development
Every year, promising drugs are abandoned. Not because they failed on safety. Not because they failed on efficacy. But because of fixable reasons: the wrong patient population, suboptimal dosing, a flawed trial design, or a business decision to walk away. Each one leaves behind years of human trial data and billions of dollars of validated science, sitting on a shelf.
Hypernova Bio exists to bring those drugs back. Using AI, chemistry, and genetic data, we reverse engineer failed and shelved compounds to diagnose exactly why they stalled, identify the patients they can actually help, and chart a smarter path to relaunch. A drug that took a decade and billions to develop becomes a de-risked, accelerated opportunity and, in many cases, a cure that already existed all along.
More Than a Company
Today, Hypernova Bio is a mission. We exist to accelerate drug discovery, recover high-potential medicines the industry left behind, and lower the cost of bringing cures to market, so breakthrough treatments can reach everyone, not just those who can afford them.
Every project we take on, and every partnership we build, is guided by one belief: Access to high-quality, affordable medicine should be a right, not a privilege.